Swiss perspectives in 10 languages

Novartis criticises new US drug pricing rules

On Thursday, Novartis reiterated its claim that the US pricing of its Entresto drug was “unconstitutional”. Prices set under the White House’s Inflation Reduction Act (IRA) will limit access to medicine, the Basel firm says.

+ Get the most important news from Switzerland in your inbox

The price-setting process is “not objective or transparent” and does not reflect the true value of a drug, Novartis wrote in a press releaseExternal link. For the Basel-based pharmaceutical giant, the new prices set under US President Joe Biden’s IRA will also have “long-lasting and devastating consequences for patients by limiting access to medicines now and in the future”.

Currently, US patients pay an average of $29 (CHF25.24) a month for Entresto, a drug to treat heart failure. The IRA, a wide-ranging program of energy transition and social reform, plans to lower the prices of ten drugs for treating serious illnesses – including Entresto – after January 2026.

+ The background on Novartis’s opposition to the IRA pricing

Under pressure, and despite strong reluctance, several major pharmaceutical companies, including Novartis, agreed to take part in negotiations with Medicare, the health insurance scheme for the over-65s in the United States.

“We acceded to a “maximum fair price” for Entresto for 2026 only to avoid other untenable options including catastrophic fines or the removal of all our products from both Medicare and Medicaid,” Novartis said in its press release.

Adapted from French by DeepL/dos

This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.

If you want to know more about how we work, have a look here, if you want to learn more about how we use technology, click here, and if you have feedback on this news story please write to english@swissinfo.ch.

Teaser: Listen to our Inside Geneva Podcast. Available on all major podcast platforms.

Popular Stories

Most Discussed

News

Swiss Post CEO Roberto Cirillo steps down at the end of March after six years

More

Swiss Post CEO to step down

This content was published on The boss of Swiss Post, Roberto Cirillo, is stepping down at the end of March after six years in the job, the company announced on Friday.

Read more: Swiss Post CEO to step down
UBS replaces CS logos on Paradeplatz

More

UBS takes over Credit Suisse’s former Zurich HQ

This content was published on The name and logo of the former Credit Suisse headquarters at Paradeplatz 8 in Zurich's financial centre were officially replaced by those of UBS on Friday.

Read more: UBS takes over Credit Suisse’s former Zurich HQ
Outgoing Fedpol chief warns of funding cuts for police work

More

Outgoing Swiss federal police chief warns of insufficient resources

This content was published on The outgoing director of the Federal Office of Police (Fedpol), Nicoletta della Valle, has warned that officers, prosecutors and investigators in Switzerland have insufficient resources to do their work.

Read more: Outgoing Swiss federal police chief warns of insufficient resources
Swiss films recorded more admissions in 2024

More

Swiss film industry reports successful year in 2024

This content was published on Swiss films did well in cinemas in 2024, recording over 907,000 admissions, the Federal Statistical Office (FSO) reports. They accounted for almost 9% of all films shown last year in Switzerland.

Read more: Swiss film industry reports successful year in 2024

In compliance with the JTI standards

More: SWI swissinfo.ch certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here . Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR